Last updated Nov 17, 2026. 1,241 unique records for ("thymosin beta-4" OR "thymosin beta 4" OR "thymosin β4" OR "thymosin β-4" OR "T beta 4" OR TB-500 OR TB500). 2026 is a partial year. This combined query counts records for thymosin beta-4 and for the commercial name TB-500 (1,241 unique records). A thymosin-beta-4-only query returns 1,216, and a TB-500-only query returns 36. The two names are not interchangeable: full-length Tβ4 findings cannot automatically be applied to a shorter fragment, and this page does not assign a sequence to the catalog vial. Source on PubMed
RC-TB4 · Tissue Signaling Research
RC-TB4
Tissue Signaling Research
Vial sizes for laboratory supply, not a protocol.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
- Catalog title
- RC-TB4 | Tissue Signaling Research
- Research focus
- Tissue Signaling Research
- Also described as
- TB-500 / thymosin beta-4 (Tβ4). The catalog does not state which sequence is in the vial.
- Format
- Lyophilized research peptide
- Catalog status
- In stock (public listing)
- Presentations
- 10 mg vialCatalog sizes, not a protocol
- Molecular formula
- No single PubChem record usedOmitted because the vial sequence (full-length Tβ4 vs fragment) is not stated
- Molecular weight
- Not listed on this pageOmitted rather than taken from a full-length Tβ4 record
- Receptor context
- Described in the literature as an actin-binding / G-actin-sequestering peptide when the subject is full-length thymosin beta-4Literature description for full-length Tβ4; research context only
- Sequence
- Not reproduced hereSee primary literature / PubChem
- Researcher access
- Sign-in required to view pricing
- PubMed records
- 1,241 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Tissue Signaling Research
RC-TB4 appears in the PEPTIDEA™ Cellular Signaling Research collection with RC-BPC, RC-BPTB4, and RC-GHK.
Sequence identity is not assigned on this page
Handbook notes state that “TB-500” may mean synthetic full-length thymosin beta-4 or a shorter fragment containing the actin-binding region. This page does not assign one sequence to the vial, and cards that concern full-length Tβ4 are labeled as such.
10 mg vial
The catalog presentation is a 10 mg vial. This page still does not assign a TB-500 / thymosin beta-4 sequence to the vial. This is a presentation of the research material, not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
| Catalog title | RC-TB4 | Tissue Signaling Research |
|---|---|
| Category | Tissue Signaling Research (Cellular Signaling Research) |
| Associated names | Listed as TB-500 / thymosin beta-4. Full-length Tβ4 is a 43-amino-acid actin-binding peptide; some commercial TB-500 materials are a shorter fragment (actin-binding region). This page does not assign one of those sequences to the vial. |
| Format | Lyophilized research peptide |
| Public catalog status | In stock (as of Nov 17, 2026) |
| Catalog presentations | 10 mg vial — sizes of the research material, not a use protocol |
| Molecular formula | No single PubChem record used (Omitted because the vial sequence (full-length Tβ4 vs fragment) is not stated, retrieved Nov 17, 2026) |
| Molecular weight | Not listed on this page (Omitted rather than taken from a full-length Tβ4 record) |
| InChIKey | Not listed on this page (PubChem) |
| Receptor context | Published papers describe full-length thymosin beta-4 as a 43-amino-acid G-actin-sequestering peptide. Some commercial materials sold as TB-500 are a shorter fragment of the actin-binding region. This page does not treat those identities as interchangeable and does not assign one of them to this catalog vial. Formula and mass are therefore omitted rather than taken from a full-length PubChem record (CID 45382195). |
| Sequence | Not reproduced on this page. See primary literature and the PubChem record. |
| Pricing | Visible after researcher sign-in |
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Horecker, Erickson-Viitanen, and Hannappel
This paper studied materials named BPC-157 and TB-500 in a rat Achilles-tendon model. The paper itself refers to TB-500 as “synthetic thymosin beta-4.” This page does not adopt that equation: full-length Tβ4 findings cannot automatically be applied to a shorter fragment, the paper’s wording does not settle which sequence was used, and this is not a study of this catalog vial.
Preparative details and any later applied uses are not restated on this page.
Ying et al.
This review surveys published work on thymosin beta-4 and actin binding. It concerns the full-length peptide as generally discussed in that literature, and those findings cannot automatically be applied to a shorter fragment.
Clinical-application wording in the review is not reproduced here.
Scheller et al.
This paper examined thymosin beta-4 in laboratory models of platelet actin equilibrium. It is a study of the named full-length peptide in a biochemical and cell setting, not a study of a shorter fragment or of this catalog vial in people.
Functional and clinical-context wording in the paper is not restated on this page.
Biçer et al.
This paper studied materials named BPC-157 and TB-500 in a rat Achilles-tendon model. It is included only to show that the commercial name TB-500 appears in later laboratory papers. It does not identify which sequence that paper used, and it is not a study of this catalog vial.
Histopathology, biomechanics, and any other findings in the paper are not reproduced here.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query ("thymosin beta-4" OR "thymosin beta 4" OR "thymosin β4" OR "thymosin β-4" OR "T beta 4" OR TB-500 OR TB500). Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
- Handle as a lyophilized research material intended for laboratory use only.
- Store according to the conditions printed on the label and in any compound document provided to approved researchers.
- Protect closed vials from moisture and unnecessary temperature swings.
- If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
- This material is not for human or veterinary use and is not medical advice.
Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.





